title: Answer to the letter of Brockow et al. concerning our article 'safety of rush insect venom immunotherapy. Results of a retrospective study in 178 patients'.
authors.forename: J
authors.initials: J
authors.lastname: Wenzel
authors.forename: M
authors.initials: M
authors.lastname: Meissner-Kraemer
authors.forename: R
authors.initials: R
authors.lastname: Bauer
authors.forename: T
authors.initials: T
authors.lastname: Bieber
authors.forename: R
authors.initials: R
authors.lastname: Gerdsen
mesh_terms: D000818:Animals; D001514:Bee Venoms / Q000009:adverse effects* / Q000276:immunology*; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007299:Insect Bites and Stings / Q000276:immunology*; D011315:Preventive Medicine; D012189:Retrospective Studies
chemical_list: D001514:Bee Venoms; D006634:Histamine H1 Antagonists